References
- Allain H, Raoul P, Lieury A, LeCoz F, Gandon JM, d ’Arbigny P. 1993. Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 15:549–558.
- Cieza A, Maier P, Poppel E. 2003. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res 34:373–381.
- Coon JT, Ernst E. 2002. Panax ginseng-. A systematic review of adverse effects and drug interactions. Drug Saf 25:323–344.
- Dimpfel W. 2005. Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (Tele-Stereo-EEG). Eur Neuropsychopharmacol 15:673–682.
- Dimpfel W, Schober F. 2001. Norepinephrine, EEG theta waves and sedation. Brain Pharmacol 1:89–97.
- Dimpfel W, Hofmann HC, Prohaska A, Schober F, Schellenberg R. 1996. Source density analysis of functional topographic EEG: Monitoring of cognitive drug action. Eur J Med Res 1:283–290.
- Dimpfel W, Wedekind W, Keplinger I. 2003. Gender difference in electrical brain activity during presentation of various film excerpts with different emotional content. Eur J Med Res 8:192–198.
- Dimpfel W, Pischel I, Lehnfeld R. 2004. Effects of lozenge containing lavender oil, extracts from hops, lemon palm and oat on electrical brain activity of volunteers. Eur J Med Res 9:423–431.
- Harmony T, Fernandez-Bouzas A, Marosi E, Fernandez T, Bernal J, Rodriguez M, Reyes A, Silva J, Alonso M, Casian G. 1993. Correlation between computed tomography and voltage and current source density spectral parameters in patient with brain lesions. Electroencephalogr Clin Neurophysiol 87:196–205.
- Kennedy DO, Wake G, Savely S, Tildesley NT, Perry EK, Wesnes KA, Scholey AB. 2003. Modulation f mood and cognitive performance following acute administration of single doses of Melissa offincinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 28:1871–1881.
- Le Bars PL, Kastelan J. 2000. Efficacy and safety of a Ginkgo biloba extract. Public Health Nutr 3:495–499.
- McKenna DJ, Jones K, Hughes K. 2001. Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 7:70–86, pp. 88–90.
- Polich J. 2004. Clinical application of the P300 event-related brain potential. Phys Med Rehabil Clin N Am 15:133–161.
- Polich J, Kok A. 1995. Cognitive and biological determinants of P300: An integrative review. Biol Psychol 41:103–146.
- Schober F, Dimpfel W. 1992. Relation between psychometric tests and quantitative topographic EEG in pharmacology. Int J Clin Pharmacol Ther Toxicol 30:428–430.
- Schober F, Schellenberg R, Dimpfel W. 1995. Reflection of mental exercise in the dynamic quantitative topographical EEG. Neuropsychobiology 31:98–112.
- Trick L, Boyle J, Hindmarch I. 2004. The effects of Ginkgo biloba extract (LI 1370) supplementation and discontinuation on the activities of daily living and mood in free living older volunteers. Phytother Res 18:531–537.
- World Medical Association Declaration of Helsinki. 2000. Ethical principles for medical research involving human subjects., 52nd WMA General assembly, Edinburgh, Scotland, October.